215 related articles for article (PubMed ID: 38442007)
1. Reply: How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury?-More needs to be known.
Zhuang Y; Szabo G
Hepatology; 2024 Jul; 80(1):E2-E3. PubMed ID: 38442007
[No Abstract] [Full Text] [Related]
2. Letter to the Editor: How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury?-More needs to be known.
Jiang L; Yang Z
Hepatology; 2024 Jul; 80(1):E1. PubMed ID: 38441997
[No Abstract] [Full Text] [Related]
3. Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1.
Zhuang Y; Ortega-Ribera M; Thevkar Nagesh P; Joshi R; Huang H; Wang Y; Zivny A; Mehta J; Parikh SM; Szabo G
Hepatology; 2024 Apr; 79(4):752-767. PubMed ID: 37725754
[TBL] [Abstract][Full Text] [Related]
4. Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases.
Yang T; Khan GJ; Wu Z; Wang X; Zhang L; Jiang Z
Drug Discov Today; 2019 Jan; 24(1):112-128. PubMed ID: 30244079
[TBL] [Abstract][Full Text] [Related]
5. [Changes in bile acid metabolism in cholestasis].
Back P
Fortschr Med; 1980 Apr; 98(16):602-5. PubMed ID: 7390373
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids.
Woolbright BL; Jaeschke H
Gene Expr; 2019 Nov; 19(3):215-228. PubMed ID: 31253204
[TBL] [Abstract][Full Text] [Related]
7. Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling.
Huang YH; Chuang JH; Yang YL; Huang CC; Wu CL; Chen CL
Lab Invest; 2009 Oct; 89(10):1128-39. PubMed ID: 19652645
[TBL] [Abstract][Full Text] [Related]
8. Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling.
Zhang L; Pan Q; Zhang L; Xia H; Liao J; Zhang X; Zhao N; Xie Q; Liao M; Tan Y; Li Q; Zhu J; Li L; Fan S; Li J; Zhang C; Cai SY; Boyer JL; Chai J
Hepatology; 2023 Jun; 77(6):1866-1881. PubMed ID: 36647589
[TBL] [Abstract][Full Text] [Related]
9. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
[TBL] [Abstract][Full Text] [Related]
10. Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis.
Pan Q; Zhang X; Zhang L; Cheng Y; Zhao N; Li F; Zhou X; Chen S; Li J; Xu S; Huang D; Chen Y; Li L; Wang H; Chen W; Cai SY; Boyer JL; Chai J
Gastroenterology; 2018 Nov; 155(5):1578-1592.e16. PubMed ID: 30063921
[TBL] [Abstract][Full Text] [Related]
11. Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.
Woolbright BL; Jaeschke H
Methods Mol Biol; 2015; 1250():363-76. PubMed ID: 26272158
[TBL] [Abstract][Full Text] [Related]
12. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
13. gamma-Glutamyltranspeptidase and bile salts in cholestatic liver.
Busachi CA; Mebis V; Desmet VJ
J Histochem Cytochem; 1977 Nov; 25(11):1283. PubMed ID: 21219
[No Abstract] [Full Text] [Related]
14. Effects of Yinzhihuang on Alleviating Cyclosporine A-Induced Cholestatic Liver Injury via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Vitro and in Vivo.
Qin Y; Tan J; Han X; Wang N; Zhai X; Lu Y
Biol Pharm Bull; 2023; 46(12):1810-1819. PubMed ID: 38044100
[TBL] [Abstract][Full Text] [Related]
15. Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang.
Yang Q; Yang F; Tang X; Ding L; Xu Y; Xiong Y; Wang Z; Yang L
BMC Complement Altern Med; 2015 Apr; 15():122. PubMed ID: 25887351
[TBL] [Abstract][Full Text] [Related]
16. Early indications of ANIT-induced cholestatic liver injury: Alteration of hepatocyte polarization and bile acid homeostasis.
Yang T; Mei H; Xu D; Zhou W; Zhu X; Sun L; Huang X; Wang X; Shu T; Liu J; Ding J; Hassan HM; Zhang L; Jiang Z
Food Chem Toxicol; 2017 Dec; 110():1-12. PubMed ID: 28986171
[TBL] [Abstract][Full Text] [Related]
17. Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.
Jia WJ; Tang QL; Jiang S; Sun SQ; Xue B; Qiu YD; Li CJ; Mao L
FEBS J; 2020 Aug; 287(15):3328-3345. PubMed ID: 31905247
[TBL] [Abstract][Full Text] [Related]
18. Bile acids in serum and bile of infants with cholestatic syndromes.
Délèze G; Paumgartner G
Helv Paediatr Acta; 1977 Jun; 32(1):29-38. PubMed ID: 617961
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Vps33b deficiency aggravates cholic acid-induced cholestatic liver injury in male mice.
Fu KL; Chen P; Zhou YY; Jiang YM; Gao Y; Zhang HZ; Guan LH; Wang CH; Liu JL; Huang M; Bi HC
Acta Pharmacol Sin; 2022 Apr; 43(4):933-940. PubMed ID: 34253877
[TBL] [Abstract][Full Text] [Related]
20. Farnesoid X receptor contributes to oleanolic acid-induced cholestatic liver injury in mice.
Feng H; Hu Y; Zhou S; Lu Y
J Appl Toxicol; 2022 Aug; 42(8):1323-1336. PubMed ID: 35128688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
